Global Smart Drugs & Pills Market worth USD 4.76 Billion by 2024

Global Smart Drugs & Pills Market worth USD 4.76 Billion by 2024

Pune, India, February 20, 2019 -- /360iResearch/ -- The report "Global Smart Drugs & Pills Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q4 2018 Update)", published by 360iResearch, states that the global market was valued at USD 1.49 billion in 2017 and is projected to reach USD 4.76 billion by 2024, growing at a CAGR of 18.11% from 2017 to 2024.

The major forces driving the growth of the smart drugs & pills market include the increased preference for less complex and painful diagnostic examinations with minimally invasive surgeries and increasing popularity of smart drug to achieve cognitive enhancement. Moreover, rise in prevalence of gastrointestinal disorders and colon cancer proactive approach to cure the potential illness technological advancements in capsule edoscopes and increased r&d investments in developing smart pills are also some of the factors that are driving the market growth. However ethical and social constraints, and potential health risk may hinder the market growth. In the middle of difficulty lies opportunity such as the rise in technological advances pertaining to smart pills such as bioelectronics, availability of microprocessors, micro-cameras, miniaturization,, and rapid development in the smart drugs and pills development process. The possible challenges for the market growth are stringent government regulations regarding the increased use of these devices, and high cost associated with the ingestible sensors. But key players in the market are overcoming the challenges with continual improvement and innovation.

Based on target area, the global smart drugs & pills market is studied across Esophagus, Large Intestine, Small Intestine, and Stomach. Based on end user, the global smart drugs & pills market is studied across Diagnostic Centers, Hospitals, and Research Institutes. Based on application, the global smart drugs & pills market is studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring. Based on geography, the global smart drugs & pills market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.

The report features a competitive scenario of the smart drugs & pills market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are Acamp, Bio-Images Research Limited, Boston Scientific Corporation, CapsoVision, Inc., Cerner Corporation, Fujifilm Holdings Corporation, GE Healthcare, Given Imaging, Inc., Karl Storz Gmbh & Co. KG, MediSafe, Medimetrics S.A. de C.V., Medtronic, Olympus Corporation, Pentax Medical Company, and Proteus digital Health.

About 360iResearch

360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.

Contact:
Miss. Shikha Sachan
Business Lead,
Nyati Elan,
Wagholi, Pune,
Maharashtra,
India - 412207.
USA: +1-530-264-8485
India: +91-9075017818
Email: [email protected]